1243 Phase I dose-escalation study of continuous oral treatment with the angiokinase inhibitor BIBF 1120 in patients with advanced solid tumors

✍ Scribed by H. Kaneda; I. Okamoto; T. Satoh; T. Arao; K. Nishio; A. Sarashina; K. Konishi; P. Stopfer; R. Kaiser; K. Nakagawa

• Book ID: 119600216
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 53 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(09)70455-0